Dilution of Per-Share Value Due to Stock Option Exercise
First written in FY2020. 11 of 13 entries say "Materialised", first in FY2021-Q3. Latest entry: 2026-11-13.
The whole theme swung hardest in 2017: 43 of 78 companies on the "Worse" side.
- 2026-11-13MaterialisedShare Issuance and Disposal
「If all of these stock acquisition rights are exercised, the total number of common shares of the company that will increase will be equivalent to 0.8% of the total number of issued shares. We recognize that enabling our outside directors to hold shares by exercising these stock acquisition rights will contribute to improving corporate value and shareholder value.」
The company resolved to issue 1,200 stock acquisition rights to outside directors, representing 120,000 common shares, thereby specifying the dilution factor from potential shares. - FY2025-H1MaterialisedAnnual report
「At a meeting of the Company's Board of Directors held on 25 January 2025, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue the stock acquisition rights to its directors as described below for the purpose of achieving medium- to long-term growth in the Company's performance and increasing corporate value. The rights were issued on 31 January 2025.」
The Company issued 774 stock acquisition rights to 1 director, representing 77,400 common shares. This added a further source of dilution from potential shares. - FY2024-Q2MaterialisedAnnual report
「At a meeting of the Company's Board of Directors held on 24 January 2024, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue the stock acquisition rights to its directors as described below for the purpose of achieving medium- to long-term growth in the Company's performance and increasing corporate value. The rights were issued on 8 February 2024.」
The Company issued 618 stock acquisition rights to 1 director, representing 61,800 common shares, adding a further source of dilution from potential shares. The exercise period is from 8 February 2024 to 7 February 2027. - FY2023MaterialisedAnnual report
「The 3,072,000-share increase in the total number of issued common shares comprised an increase of 2,904,000 shares from a third-party allotment and 168,000 shares from the exercise of stock acquisition rights.」
Dilution continued to occur as a result of the third-party allotment and exercise of stock acquisition rights. The number of potential shares at the end of the period was 398,000. - FY2023-Q2MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
From 1 January to 7 February 2023, the number of shares increased by 80,000 upon the exercise of stock acquisition rights, and dilution continued to occur. - FY2023-Q1MaterialisedAnnual report
「The issuance of 2,904,000 new shares through a third-party allotment with a payment date of 16 December 2022 increased capital stock and capital surplus by ¥342.672 million each.」
The Company issued 2,904,000 shares through a third-party allotment to Hirao Jo (平尾丈) and ZIGExN Co.,Ltd., resulting in new dilution of share value. - FY2022MitigatedAnnual report
「14 classes of stock acquisition rights (number of stock acquisition rights: 1,072,184 common shares).」
The number of potential shares decreased from 1,379,424 at the end of the previous fiscal year to 1,072,184. Dilution from the exercise of rights occurred, but the number of remaining potential shares decreased. - FY2022-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
From April to June 2022, the number of shares increased by 8,200 upon the exercise of stock acquisition rights, and dilution from the exercise of potential shares continued to occur. - FY2022-Q2MaterialisedAnnual report
「1 January 2022–31 March 2022 (Note) 24,200」
From January to March 2022, the number of shares increased by 24,200 upon the exercise of stock acquisition rights, and dilution continued to occur. - FY2022-Q1MaterialisedAnnual report
「1 October 2021–31 December 2021 (Note) 110,600」
During the first quarter, the number of shares increased by 110,600 upon the exercise of stock acquisition rights, and dilution from the exercise of potential shares continued to occur. - FY2021MaterialisedAnnual report
「The 1,015,300-share increase in the total number of issued common shares comprised increases of 200,000 shares from the public offering in connection with the initial listing, 722,700 shares from a third-party allotment and 92,600 shares from the exercise of stock acquisition rights.」
During the fiscal year, 92,600 shares were issued upon the exercise of stock acquisition rights, reducing the number of potential shares from 1,492,984 at the end of the previous fiscal year to 1,379,424. - FY2021-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
From April to June 2021, 45,880 shares were issued upon the exercise of stock acquisition rights, bringing the number of shares issued as of the filing date to 11,627,804. Dilution from the exercise of potential shares actually occurred. - FY2020First statedAnnual report
「As of the filing date, the number of potential shares represented by stock acquisition rights was 1,491,144, equivalent to 12.9% of the total number of shares issued.」
The Company described the potential dilution of existing shareholders' share value and voting rights.